Ori Biotech Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 73

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $101M

  • Investors
  • 13

Ori Biotech General Information

Description

Developer of cell and gene therapy (CGT) technology designed for process discovery, translation, and scalable commercialization of cells and genes. The company's manufacturing platform automates CGT manufacturing to increase throughput, improve quality, and decrease costs by combining proprietary hardware, software, data, and analytics, enabling therapeutics developers to develop and bring products to market at a commercial scale and patients to access personalized and life-saving treatments.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5-10 Brandon Road
  • London N7 9AA
  • England, United Kingdom
Primary Industry
Other Devices and Supplies
Other Industries
Biotechnology
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • 5-10 Brandon Road
  • London N7 9AA
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ori Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series B) 07-Jan-2022 $101M Completed Generating Revenue
5. Later Stage VC (Series A) 24-Aug-2020 Completed Generating Revenue
4. Grant 01-May-2020 Completed Generating Revenue
3. Seed Round 22-Aug-2019 Completed Generating Revenue
2. Angel (individual) 04-May-2018 $270K $456K Completed Generating Revenue
1. Angel (individual) 29-Nov-2016 $187K $187K Completed Generating Revenue
To view Ori Biotech’s complete valuation and funding history, request access »

Ori Biotech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Ordinary
Series A
Ordinary
Seed Preferred
Seed Ordinary
Seed Ordinary
Ordinary
Ordinary 134,584 $0.000134 $0.6 $0.6 1x $0.6 0.42%
Ordinary 60,900 $0.000134 $0.6 $0.6 1x $0.6 0.19%
To view Ori Biotech’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Ori Biotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of cell and gene therapy (CGT) technology designed for process discovery, translation, and scalable commercial
Other Devices and Supplies
London, United Kingdom
73 As of 2023

South San Francisco, CA
 

San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ori Biotech Competitors (8)

One of Ori Biotech’s 8 competitors is Cellares, a Venture Capital-Backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cellares Venture Capital-Backed South San Francisco, CA
Multiply Labs Venture Capital-Backed San Francisco, CA
TrakCel Venture Capital-Backed Cardiff, United Kingdom
Therapure Biopharma Formerly PE-Backed Mississauga, Canada
Celonic Corporate Backed or Acquired Basel, Switzerland
You’re viewing 5 of 8 competitors. Get the full list »

Ori Biotech Patents

Ori Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202509075-D0 A method Pending 09-Jun-2025
GB-202509076-D0 Method of mixing particles in a liquid medium Pending 09-Jun-2025
GB-202505841-D0 A connector Pending 17-Apr-2025
GB-202505842-D0 A connector Pending 17-Apr-2025
WO-2026220158-A1 A connector Pending 17-Apr-2025 A61M39/105
To view Ori Biotech’s complete patent history, request access »

Ori Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ori Biotech Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
Chimera Capital PE/Buyout Minority
Angel (individual) Minority
Novalis LifeSciences Venture Capital Minority
Angel (individual) Minority
You’re viewing 5 of 13 investors. Get the full list »

Ori Biotech FAQs

  • When was Ori Biotech founded?

    Ori Biotech was founded in 2015.

  • Where is Ori Biotech headquartered?

    Ori Biotech is headquartered in London, United Kingdom.

  • What is the size of Ori Biotech?

    Ori Biotech has 73 total employees.

  • What industry is Ori Biotech in?

    Ori Biotech’s primary industry is Other Devices and Supplies.

  • Is Ori Biotech a private or public company?

    Ori Biotech is a Private company.

  • What is the current valuation of Ori Biotech?

    The current valuation of Ori Biotech is .

  • What is Ori Biotech’s current revenue?

    The current revenue for Ori Biotech is .

  • How much funding has Ori Biotech raised over time?

    Ori Biotech has raised $140M.

  • Who are Ori Biotech’s investors?

    , Chimera Capital, , Novalis LifeSciences, and are 5 of 13 investors who have invested in Ori Biotech.

  • Who are Ori Biotech’s competitors?

    Cellares, Multiply Labs, TrakCel, Therapure Biopharma, and Celonic are some of the 8 competitors of Ori Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process